The GLP-1 reading room
Practical reading for a more informed conversation with your clinician.
Your first hour learning about GLP-1
A reading plan for the moment when an unfamiliar treatment becomes a personal question.
Read the guide ↗ Comparison guideComparing semaglutide and tirzepatide without losing the context
How to examine two treatment discussions without reducing the choice to a headline or a brand.
Read the guide ↗ Appointment preparationThe questions to settle before joining an online care program
A practical agenda for the conversation between browsing a service and agreeing to its terms.
Read the guide ↗ Money and accessBudgeting for care across the whole commitment
Follow the payment timeline to understand what an advertised monthly price leaves out.
Read the guide ↗ Product identityReading a compounded medication offer carefully
What to clarify when a familiar ingredient appears in a compounded product description.
Read the guide ↗ Product identityCompounded tirzepatide: identify the actual proposal
An ingredient name is the beginning of a product description, not the end of it.
Read the guide ↗ Formulation questionsCompounded semaglutide: questions hidden by a familiar name
How to avoid treating ingredient recognition as complete product knowledge.
Read the guide ↗ Hormone-care researchEstradiol: read the route as well as the name
A hormone-care listing needs its own purpose, product description and clinical discussion.
Read the guide ↗ Hormone-care contextProgesterone: understand its place in the proposed plan
Before comparing an offer, establish the reasoning behind its inclusion.
Read the guide ↗ Local treatment terminologyVaginal estradiol: why the local product description matters
Use the complete name to keep a specific discussion from becoming a broad hormone comparison.
Read the guide ↗ Wellness claimsNAD+ offerings: test the claim before judging the package
A framework for reading a longevity-labelled service with a more precise set of questions.
Read the guide ↗ Evidence questionsSermorelin listings: a closer look at the longevity pitch
How to separate an aspirational category from an adequately explained proposal.
Read the guide ↗ Brand-name researchOzempic in an online offer: familiarity is not a full assessment
Recognising a brand does not establish the prescription, indication or commercial arrangement.
Read the guide ↗ Offer verificationWegovy pill listings: verify the formulation and availability
Treat an oral-product listing as something to confirm, not proof that a particular service can supply it.
Read the guide ↗ Category explainerNon-hormonal care: turn a category into a concrete discussion
A broad label cannot tell you which intervention a clinician has in mind.
Read the guide ↗